Recent Updates
Recently added Catalysts
WST Positive Sentiment

West to Participate in Upcoming Investor Conferences

Key Takeaway: West Pharmaceutical Services, Inc. (NYSE: WST) will present at two upcoming investor conferences: the Wells Fargo Annual Healthcare Conference on September 10, 2026, and the Morgan Stanley Annual Global Healthcare Conference on September 14, 2026. Live webcasts will be available on the company's website, with replays accessible for 90 days post-event. West is recognized for its innovative injectable solutions and reported $3.07 billion in net sales for fiscal year 2025.
Price reaction · baseline $349.92 (2026-08-26 close) · hit after-hours · clean, no other WST news in the window
day 0 close · peak
-1.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • West Pharmaceutical Services is participating in major investor conferences.
  • The company continues to showcase its leadership in injectable drug administration.
  • Strong financial performance with $3.07 billion in net sales for fiscal year 2025.

Full Press Release Details

EXTON, Pa., Aug. 26, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the following upcoming investor conferences:
• Wells Fargo Annual Healthcare Conference on Thursday, September 10, 2026 at 8:45 a.m. EDT in Everett, MA
• Morgan Stanley Annual Global Healthcare Conference on Monday, September 14, 2026 at 8:30 a.m. EDT in New York, NY
The live webcasts for these events can be accessed in the Investors section of the Company's website. A replay of each webcast will also be available on the Company's website for approximately 90 days after each respective event.
About West West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites including 26 manufacturing facilities worldwide, West helps support our customers by delivering over 41 billion components and devices each year.
Headquartered in Exton, Pennsylvania, West in its fiscal year 2025 generated $3.07 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor's 500 index. For more information, visit www.westpharma.com.
All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.

Frequently Asked Questions

What investor conferences will West participate in?

West will present at the Wells Fargo Annual Healthcare Conference and the Morgan Stanley Annual Global Healthcare Conference.

When is the Wells Fargo Annual Healthcare Conference?

The Wells Fargo Annual Healthcare Conference is scheduled for September 10, 2026.

How can I access the webcasts for the conferences?

Live webcasts can be accessed in the Investors section of West's website.

What was West's net sales for fiscal year 2025?

West generated $3.07 billion in net sales for fiscal year 2025.

Last updated: Aug 26, 2026